February 2, 2011
Emory Hotel & Conference Center

Artifacts from 2nd Annual Academic & Industry Intersection Conference


Recognizing the interdependence of the efforts between academia, industry, non-profits, foundations, private investment, and government needed to move scientific discoveries to practical application, the Second Annual Academic & Industry Intersection Conference seeks to profile successful collaborations as well as examine potential ethical pitfalls related to the life science partnerships.


ACTSI, led by Emory University with partners Morehouse School of Medicine and Georgia Institute of Technology, and Georgia Bio, the state's life sciences industry association, organized this conference to provide critical information on how academia and industry along with other important players can work together.


The program included panelists from academia, industry, non-profits, foundations, private investment, and government discussing the challenges and successes of their relationships. In addition, Emory President James Wagner delivered the keynote address discussing ethical considerations of academic industry partnerships.


The 2011 Academic & Industry Intersection Conference focused on ethical issues involved in translating academic research into commercial therapeutics, devices, and other technologies aimed at improving health and prolonging life.

Noon-12:30 p.m. Registration Opens / Networking / Exhibition Viewing

12:30-12:40 p.m. Introductory Remarks
Charles Craig, President, Georgia Bio
David S. Stephens, MD, Principal Investigator, Atlanta Clinical & Translational Science Institute, Vice President for Research, Robert W. Woodruff Health Sciences Center, Emory University

12:40-1:15 p.m. Keynote Address James W. Wagner, PhD, President, Emory University

1:15-2:00 p.m. Session I: Ethical Concerns Facing Academic Industry Collaborations
John D. Banja, PhD, Professor, Department of Rehabilitation Medicine, Medical Ethicist, Center for Ethics, Director, Ethics Section, Atlanta Clinical & Translational Science Institute
Robert Popovian, Pharm.D., MS., Sr. Director, Advocacy and Professional Relations, Worldwide Biopharmaceutical Businesses (WBB), US Public Affairs, Pfizer Inc., Granada Hills, CA

2:00-2:30 p.m. Break & Exhibition Viewing

2:30-3:30 p.m. Session II : Case Studies of IP Development Involving Academia, Grant Support, Industry and Venture Capital
Greg Dane, Director of Innovation, Coulter Project Director, The Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University
Tak Cheung, Senior Manager, Business Development, Heart Valve Therapy Group, Edwards Lifesciences Corporation
Jim Greene, Chief Executive Officer, Apica Cardiovascular Limited
Vinod Thourani, MD, Associate Professor of Cardiothoracic Surgery, Emory University School of Medicine

3:30-3:45 p.m. Break & Exhibition Viewing

3:45-4:30 p.m. Session III: Government, Academic, Non-profit, Industry Partnerships to Improve Global Health
James W. Curran, MD, MPH, Dean, Rollins School of Public Health, Emory University
Russell M. Medford, MD, PhD, Scientific Co-founder, President & CEO, Salutria Pharmaceuticals
Raymond F. Schinazi, PhD, Frances Winship Walters Professor, Director, Laboratory of Biochemical Pharmacology, Senior Research Career Scientist, Director, Virology/Drug Discovery Core, Emory Center for AIDS Research, Department of Pediatrics, School of Medicine, Emory University, VA Medical Center

4:30-6:30 p.m. Networking Reception & Exhibition Viewing